%0 Journal Article
%T Prognostic value of gross tumor volume delineated by FDG-PET-CT based radiotherapy treatment planning in patients with locally advanced pancreatic cancer treated with chemoradiotherapy
%A Cem Parlak
%A Erkan Topkan
%A Cem Onal
%A Mehmet Reyhan
%A Ugur Selek
%J Radiation Oncology
%D 2012
%I BioMed Central
%R 10.1186/1748-717x-7-37
%X A total of 30 patients with histological proof of LAPC underwent 50.4 Gy (1.8 Gy/28 fractions) of radiotherapy concurrent with continuously infused 5-FU followed by 4 to 6 courses of maintenance gemcitabine. Target volume delineations were performed on FDG-PET-CT-based RTP. Patients were stratified into 2 groups: GTV lesser (GTVL) versus greater (GTVG) than cut off value determined by receiver operating characteristic (ROC) analysis, and compared in terms of OS, LRPFS and PFS.Median GTV delineated according to the FDG-PET-CT data was 100.0 cm3. Cut off GTV value determined from ROC curves was 91.1 cm3. At a median follow up of 11.2 months, median OS, LRPFS and PFS for the entire population were 10.3, 7.8 and 5.7 months, respectively. Median OS, LRPFS and PFS for GTVL and GTVG cohorts were 16.3 vs. 9.5 (p = 0.005), 11.0 vs. 6.0 (p = 0.013), and 9.0 vs. 4.8 months (p = 0.008), respectively.The superior OS, LRPFS and PFS observed in GTVL patients over GTVG ones suggests a potential for FDG-PET-CT-defined GTV size in predicting outcomes of LAPC patients treated with definitive C-CRT, which needs to be validated by further studies with larger cohorts.Concurrent chemoradiotherapy (C-CRT) has been a well-established treatment option for patients with locally-advanced pancreas cancer (LAPC), which constitutes approximately one third of pancreatic carcinomas (PC) [1,2]. In spite of significant improvements in diagnostic imaging, chemotherapy, and radiotherapy (RT), outcome in LAPC is still dismal with median overall survival (OS) rarely exceeding 1 year even following aggressive C-CRT [3,4].Several surgical series have established factors including tumor size, status of resection margins, invasion of vascular and/or adjacent structures, degree of differentiation, performance status, carbohydrate antigen 19-9 and C-reactive protein levels, to affect the outcome in resectable PC [2]. However, there are only few series indicating prognostic factors in the LAPC [4-7], while none
%K Locally advanced pancreatic carcinoma
%K Chemoradiotherapy
%K FDG-PET-CT based RTP
%K Gross tumor volume
%U http://www.ro-journal.com/content/7/1/37